| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/09/1992 | EP0314764B1 Injectable opacifying liposome composition |
| 09/09/1992 | CN1064218A Filler for opthalmic clinic examination |
| 09/08/1992 | US5145863 Porphyrin compounds |
| 09/08/1992 | US5145684 Dispersion, bioavailability |
| 09/08/1992 | US5145661 Polymer-coated magnetite |
| 09/08/1992 | CA2062483A1 Chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014695A1 New polyiodated compounds, method of preparation, contrast product containing them |
| 09/03/1992 | WO1992014539A1 Process of concentration and purification of organic compounds |
| 09/03/1992 | WO1992014493A1 Non-protein intracellular receptor binding conjugates and a method of use thereof |
| 09/03/1992 | DE4106047A1 Dyeing injury to joint meniscus - using e.g. methylene blue, non-toxic strong dye which quickly reveals the injury after injection or during arhroscopy |
| 09/03/1992 | CA2104786A1 New polyiodated compounds, method of preparation, contrast product containing them |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | WO1992015284A1 Gas and oxygen carrying lipid vesicles |
| 09/02/1992 | EP0501875A1 Poly-iodinated compounds, process of preparation, contrast agents containing them |
| 09/02/1992 | EP0500919A1 Novel magnetic resonance imaging agents |
| 09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 09/02/1992 | EP0437488A4 Animal model for human disease |
| 09/02/1992 | CA2106405A1 Gas and oxygen carrying lipid vesicles |
| 09/01/1992 | US5143716 In combination with paramagnetic ion |
| 09/01/1992 | US5143715 Organic contrast agent analog and method of making same |
| 08/26/1992 | EP0500023A1 Abdominal ultrasound imaging |
| 08/26/1992 | EP0480925A4 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 08/25/1992 | US5141876 Quatitative analysis of proteins in urine sampling by complexing with first antibodies and second antibodies with radioactive label |
| 08/25/1992 | US5141740 Medical diagnosis |
| 08/25/1992 | US5141739 Delivery of x-ray contrast agents using receptor mediated endocytosis |
| 08/25/1992 | US5141738 Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof |
| 08/23/1992 | WO1992014821A2 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | CA2104697A1 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | CA2061116A1 Abdominal ultrasound imaging |
| 08/20/1992 | WO1992013841A1 Complexing agents |
| 08/20/1992 | WO1992004916A3 Particulate agents |
| 08/19/1992 | EP0499501A2 New macrocyclic nitrogen ligands, method for their preparation, metal complexes, diagnostic and therapeutic compositions |
| 08/19/1992 | EP0499299A2 Surface modified drug nanoparticles |
| 08/15/1992 | WO1992014841A1 Novel lanthanide chelate-conjugated oligonucleotides |
| 08/12/1992 | EP0498482A2 X-ray contrast compositions useful in medical imaging |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498380A1 Complexing agents |
| 08/12/1992 | EP0497926A1 Multi-site metal chelating agents |
| 08/12/1992 | EP0365541B1 Preparation of 5-acylamino-2,4,6-triiodo- or tribromo-benzoic acid derivatives |
| 08/11/1992 | US5138058 Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof |
| 08/11/1992 | US5138040 Composition for magnetic resonance imaging |
| 08/11/1992 | US5138039 Diagnosis, therapy |
| 08/11/1992 | US5137928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
| 08/11/1992 | US5137712 Use of s-adenosyl-l-methionine (SAMe) to reverse and/or prevent supersensitivity, tolerance and extrapyramidal side effects induced by neuroleptic treatment |
| 08/11/1992 | US5137711 Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents |
| 08/06/1992 | WO1992012735A1 Composition containing ultrafine particles of magnetic metal oxide |
| 08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 08/05/1992 | EP0472522A4 Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics |
| 08/05/1992 | EP0344202B1 Iodized polymers, processes for their preparation and their applications as contrast products |
| 08/05/1992 | CN1063360A Process for detection and localization of cancer |
| 08/04/1992 | US5135850 Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive age |
| 08/04/1992 | US5135737 Amplifier molecules for enhancement of diagnosis and therapy |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/04/1992 | CA1305922C Method of myocardial imaging |
| 07/30/1992 | DE4101910A1 Verfahren zur herstellung eines pyrogenfreien gut wasserloeslichen fructans sowie ein nierendiagnostikum, das ein solches fructan enthaelt Process for the preparation of a pyrogen well wasserloeslichen fructans and a renal diagnostic that such a fructan contains |
| 07/29/1992 | CN1017652B Invivo cellular tracking |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/26/1992 | CA2059431A1 X-ray contrast compositions useful in medical imaging |
| 07/25/1992 | WO1992012978A1 Novel nitrogenous macrocyclic ligands, their preparation method, polymetallic complexes, and a diagnostic and therapeutical composition |
| 07/25/1992 | CA2078983A1 Nitrogen macrocyclic ligands, preparation method, complex polymetallic diagnostic composition and therapeutical |
| 07/24/1992 | WO1992013005A1 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function |
| 07/23/1992 | WO1992011873A1 Echo contrast agent |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/23/1992 | WO1992011840A1 Contrast agents for magnetic-resonance imaging |
| 07/23/1992 | WO1992011807A1 Process fot the detection and localization of cancer |
| 07/22/1992 | EP0495287A2 Magnetic resonance imaging |
| 07/22/1992 | EP0494974A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 07/22/1992 | EP0406281B1 Gestation-recognizing protein |
| 07/21/1992 | US5132409 Macrocyclic chelating agents and chelates thereof |
| 07/21/1992 | US5132292 Treatment of viral hepatitis |
| 07/15/1992 | EP0494616A1 Contrast agent for MR diagnosis |
| 07/15/1992 | EP0494615A1 Echo contrast agent |
| 07/15/1992 | EP0393104B1 Measurement of pge 2 (prostaglandin e 2) levels in patients with chronic inflammatory bowel disease |
| 07/14/1992 | US5130437 Chelate compounds for detoxification and NMR imaging |
| 07/14/1992 | US5130431 Chelate compound intermediates an NMR contrast agents |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130120 Diethylenetriaminepentaacetic acid or ethylenediamine tetraacetic acid for magnetic resonance imaging |
| 07/14/1992 | US5130119 Method of using fluorosubstituted benzene derivatives in f-nmr imaging |
| 07/14/1992 | CA1305133C Fluorogenic and chromogenic three-dimensional ionophores as selective reagents for detecting ions in biological fluids |
| 07/11/1992 | WO1992011863A1 Amylin activity assays |
| 07/11/1992 | WO1992011862A1 Hyperglycemic compositions |
| 07/11/1992 | CA2077265A1 Amylin activity assays |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/08/1992 | CN1062468A Method for production of ultrasonic coupling agent |
| 07/07/1992 | US5128121 Mixture of a positive and negative contrast agent for magnetic resonance imaging |
| 07/07/1992 | US5128120 Quantitative determination of compounds in blood or urine |
| 07/07/1992 | US5128069 Luciferin derivatives |
| 07/07/1992 | US5127408 Apparatus for intravascularly measuring oxidative metabolism in body organs and tissues |
| 07/02/1992 | DE4041351A1 Test antigen for diagnosis of legionellosis and listeriosis - comprises soluble cell components of Legionella, Listeria or Brochothrix |
| 07/01/1992 | EP0492707A2 Hydrophilic form of perfluoro compounds and method of manufacture |
| 07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
| 06/30/1992 | US5126440 Iodinated polymers with dextran skeleton, processes for their preparation and their uses as contrast products |
| 06/30/1992 | US5126122 Preferential bonding to tumor |
| 06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491594A1 Contrast agent comprising a neutral complex of a paramagnetic cation and ligand for forming a complex |
| 06/24/1992 | EP0490917A1 Contrast media |
| 06/24/1992 | EP0490897A1 Novel magnetic resonance imaging agents |